All In Biotech

Free tool

FAERS Monitor: Casodex

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022310 or its brand name (Casodex, Bicalutamide). Reports on generic versions are filed under their own applications.

Reports

15,314

Serious

12,703

83% of reports

Hospitalization

5,517

Death reported

2,753

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue1,344
  • death1,010
  • prostatic specific antigen increased951
  • asthenia819
  • hot flush804
  • prostate cancer757
  • malignant neoplasm progression725
  • drug ineffective613
  • dizziness590
  • nausea569
  • dyspnoea553
  • diarrhoea537
  • decreased appetite521
  • anaemia506
  • metastases to bone434

Reports by year received

View as table
YearReports
2004224
2005268
2006264
2007235
2008483
2009606
2010505
2011469
2012433
2013560
2014651
2015884
20161,115
20171,170
20181,305
20191,011
2020870
2021890
2022944
2023693
2024631
2025735
2026368

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,038,845 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
prostatic specific antigen increasedSignal951101.895.588,296
metastases to boneSignal43437.333.914,892
hot flushSignal80414.813.810,257
prostate cancerSignal75713.012.28,356
malignant neoplasm progressionSignal7259.89.15,697
anaemiaSignal5063.73.4978
decreased appetiteSignal5213.12.8739
astheniaSignal8193.02.81,104
fatigueSignal1,3442.42.31,106
dizziness5901.61.5145
death1,0101.61.5243
dyspnoea5531.31.249
diarrhoea5371.11.110
nausea5691.00.90
drug ineffective6130.60.6133

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.